Targeting Autophagy in Breast Cancer

Stefania Cocco1, Alessandra Leone2, Michela Piezzo1

  • 1Breast Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Via Mariano Semmola 53, 80131 Napoli, Italy.

Insights

Breast cancer drug resistance can be overcome by targeting autophagy, a cellular process. Inhibiting autophagy may enhance cancer cell death when combined with targeted therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cellular Biology

Background:

  • Breast cancer is a complex disease with diverse subtypes, impacting treatment response and progression.
  • Targeted therapies (e.g., PI3K/Akt/mTOR, cyclinD/CDK/pRb pathways) are used, but drug resistance is a significant challenge.
  • Autophagy, a cellular degradation process, can be activated by cancer drugs as a survival mechanism.

Purpose of the Study:

  • To review the role of autophagy in breast cancer.
  • To explore the interplay between autophagy and targeted breast cancer therapies.
  • To discuss autophagy inhibition as a strategy to overcome drug resistance.

Main Methods:

  • Literature review of scientific articles on breast cancer, autophagy, and targeted therapies.
  • Analysis of molecular mechanisms underlying autophagy activation and drug resistance.
  • Synthesis of current research on targeting autophagy in breast cancer treatment.

Main Results:

  • Autophagy can promote cancer cell survival, contributing to resistance against targeted drugs.
  • Inhibiting autophagy in combination with targeted therapies shows potential for enhancing anti-tumor effects.
  • Understanding autophagy modulation is crucial for developing effective breast cancer treatments.

Conclusions:

  • Autophagy plays a dual role in breast cancer, but its inhibition is a promising strategy to combat drug resistance.
  • Targeting autophagy offers a novel therapeutic avenue to improve outcomes for breast cancer patients.
  • Further research is needed to optimize autophagy-targeted therapies for clinical application.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.4K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
7.7K